Cote Elissa S.
SEC insider (Form 3/4/5 filer). CIK 0002069951. Chief Corp Development Officer at Vistagen Therapeutics, Inc. (VTGN). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Cote Elissa S. has filed insider reports for
- Vistagen Therapeutics, Inc. (VTGN): Officer, Chief Corp Development Officer
Cote Elissa S.
CIK: 0002069951
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VTGN
Vistagen Therapeutics, Inc.
Officer